Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Haisco Pharmaceutical Group Co., Ltd. clinical trials
The registry lists 155 studies whose lead sponsor is Haisco Pharmaceutical Group Co., Ltd. or one of 3 companies grouped under it. 49 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 29, 2026.
Keep track of what changes. Save the Haisco Pharmaceutical Group Co., Ltd. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesStatus
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Haisco Pharmaceutical Group Co., Ltd..
- Haisco Pharmaceutical Group Co., Ltd.114 studiesSame company
Something wrong?
- Sichuan Haisco Pharmaceutical Group Co., Ltd30 studies →Subsidiary
Something wrong?
- Haisco-USA Pharmaceuticals, Inc.6 studies →Regional office
Something wrong?
- Xizang Haisco Pharmaceutical Co., Ltd5 studies →Subsidiary
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 50 of 155. Browse all 155 →
- A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASHRecruitingNCT07581951Phase 3
- HSK42360-Na Tablets Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal CancerRecruitingNCT07790510Phase 1/2
- Evaluating the Efficacy and Safety of of HSK50042 in People With Idiopathic Pulmonary FibrosisNot yet recruitingNCT07728721Phase 2
- HSK41959 With Standard Therapy in Solid Tumors With MTAP DeletionNot yet recruitingNCT07699757Phase 1
- A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of HSK46256 in Patients With Advanced Solid TumorsNot yet recruitingNCT07695142Phase 1
- First-in-human Study of HSK56630 in Healthy SubjectsRecruitingNCT07580794Phase 1
- A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of HSK39004 Inhalation Suspension in Patients With COPDNot yet recruitingNCT07658339Phase 3
- A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase III Study of HSK39004 Inhalation Powder for the Treatment of COPDRecruitingNCT07583849Phase 3
- Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler and HSK39004 Inhalation Suspension in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD)RecruitingNCT07140328Phase 2
- Long-Term Safety and Efficacy of HSK39004 Inhalation Suspension in COPDNot yet recruitingNCT07634367Phase 3
- A Study to Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA NephropathyRecruitingNCT07616700Phase 2
- A Study to Assess the Safety of HSK31858 in Participants With Non-Cystic Fibrosis BronchiectasisRecruitingNCT07616375Phase 3
- A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Abdominal SurgeryRecruitingNCT07533786Phase 2
- Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgANRecruitingNCT07390123Phase 3
- Phase I Study of HSK42360-Na in Solid Tumors With BRAF V600 MutationRecruitingNCT07561554Phase 1
- A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Orthopedic SurgeryNot yet recruitingNCT07551739Phase 2
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of HSK44459 Tablets in Patients With Idiopathic Pulmonary FibrosisNot yet recruitingNCT07519070Phase 3
- A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Food Effect of HSK55879 Tablets in Healthy Subjects.RecruitingNCT07521345Phase 1
- HSK3486 (Cipepofol) Injectable Emulsion for Induction of General Anesthesia in Pediatric Subjects Undergoing Elective SurgeryNot yet recruitingNCT07510945Phase 3
- Evaluating the Efficacy and Safety of of HSK44459 in People With Progressive Pulmonary FibrosisNot yet recruitingNCT07503587Phase 3
- A Study for HSK47388 in Participants With Ulcerative ColitisRecruitingNCT07335055Phase 2
- Long-Term Safety and Efficacy of HSK39004 Dry Powder Inhaler in COPDNot yet recruitingNCT07425210Phase 2
- Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LNRecruitingNCT07363460Phase 2
- Clinical Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HSK31858 in Healthy SubjectsEnrolling by invitationNCT07134465Phase 1
- A Study to Assess PK, Safety and Efficacy of HSK47977 Tablets in Subjects With Relapsed or Refractory Non-Hodgkin's LymphomaRecruitingNCT07283796Phase 1
- A Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Study Comparing the Efficacy and Safety of Cofrogliptin Versus Acarbose in Drug-Naïve Patients With Type 2 DiabetesNot yet recruitingNCT07122102Not applicable
- Phase I Study of HSK42360 in Malignant Brain Tumors With BRAF V600 MutationRecruitingNCT07158710Phase 1
- A Phase 2 Study of HSK47388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate-to-Severe Plaque PsoriasisNot yet recruitingNCT07158268Phase 2
- Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HSK39297 in Subjects With Hepatic ImpairmentRecruitingNCT07152288Phase 1
- A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque PsoriasisNot yet recruitingNCT07150988Phase 2
- A Long-term Study of HSK44459 Tablets in Participants With Bechet's DiseaseNot yet recruitingNCT07070739Phase 2
- Long-term Safety and Efficacy Study of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF)Not yet recruitingNCT07019090Phase 2
- Phase I Study of HSK46575 in Patients With Metastatic Castration-Resistant Prostate CancerRecruitingNCT07007910Phase 1
- Phase I Study of HSK41959 in Solid Tumors With MTAP DeletionRecruitingNCT06968572Phase 1
- This Study is to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of HSK47388 in Healthy VolunteersNot yet recruitingNCT06926218Phase 1
- Evaluating the Efficacy and Safety of of HSK44459 in Patients With Behçet's DiseaseNot yet recruitingNCT06902428Phase 2
- A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Airway Mucus HypersecretionEnrolling by invitationNCT06820749Phase 2
- A Study to Evaluate the Accuracy of aTCI Model of Cipepofol in Patients With General Anesthesia During Elective SurgeryRecruitingNCT06740201Phase 4
- A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Bronchial AsthmaEnrolling by invitationNCT06637254Phase 2
- Long-term Safety and Tolerability of HSK39297 in Patients With Paroxysmal Nocturnal HemoglobinuriaRecruitingNCT06745622Phase 2
- A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis BronchiectasisRecruitingNCT06660992Phase 3
- Phase I Study of HSK42360 in Solid Tumors With BRAF V600 MutationRecruitingNCT06536400Phase 1
- Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain Who Had an Inadequate Response to PregabalinRecruitingNCT06490484Phase 2
- Efficacy and Safety of HSK16149 Capsule in the Treatment of Moderate and Severe Central Neuropathic Pain in ChinaNot yet recruitingNCT06422117Phase 3
- A Study for HSK39775 in Participants With Solid TumorsRecruitingNCT06314373Phase 1/2
Sponsor listed in the registry: Xizang Haisco Pharmaceutical Co., Ltd
- A Study of HSK21542 in a Peritoneal Dialysis Pruritus Population.Not yet recruitingNCT06290375Phase 2
Sponsor listed in the registry: Xizang Haisco Pharmaceutical Co., Ltd
- To Evaluate the Efficacy and Safety of HSK16149 With L-carnitine in Diabetic Peripheral Neuralgia Patients in ChinaRecruitingNCT06122012Not applicable
- Phase I Study of HSK40118 in NSCLC Patients With EGFR MutationRecruitingNCT06050980Phase 1
- A Study to Evaluate the Pharmacokinetics of HSK21542 in Subjects With Renal ImpairmentRecruitingNCT05947097Phase 1
- A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment in Orthopedic SurgeryCompletedNCT07442877Phase 2